These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2311011)

  • 1. Association between Alzheimer disease and amyotrophic lateral sclerosis?
    Frecker MF; Fraser FC; Andermann E; Pryse-Phillips WE
    Can J Neurol Sci; 1990 Feb; 17(1):12-4. PubMed ID: 2311011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal lobe pathology in amyotrophic lateral sclerosis. Do amyotrophic lateral sclerosis and Alzheimer's disease share a common etiological factor?
    Smitt PA; Troost D; Louwerse ES; de Jong JM; van Kessel DT; de Leeuw MA
    Clin Neuropathol; 1993; 12(2):88-91. PubMed ID: 8477553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper mediated neurological disorder: visions into amyotrophic lateral sclerosis, Alzheimer and Menkes disease.
    Ahuja A; Dev K; Tanwar RS; Selwal KK; Tyagi PK
    J Trace Elem Med Biol; 2015 Jan; 29():11-23. PubMed ID: 24975171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mouse models of Alzheimer's disease and amyotrophic lateral sclerosis.
    Borchelt DR; Wong PC; Sisodia SS; Price DL
    Brain Pathol; 1998 Oct; 8(4):735-57. PubMed ID: 9804381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C9orf72 mutations do not influence the tau signature of amyotrophic lateral sclerosis with cognitive impairment (ALSci).
    Volkening K; Strong WL; Seaton S; Yang W; Strong MJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):549-554. PubMed ID: 28562075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No Geographic Correlation between Lyme Disease and Death Due to 4 Neurodegenerative Disorders, United States, 2001-2010.
    Forrester JD; Kugeler KJ; Perea AE; Pastula DM; Mead PS
    Emerg Infect Dis; 2015 Nov; 21(11):2036-9. PubMed ID: 26488307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis caused by neurotoxins?
    Vandervort WJ
    Del Med J; 1987 Aug; 59(8):533-4, 537. PubMed ID: 3666247
    [No Abstract]   [Full Text] [Related]  

  • 8. [Amyotrophic lateral sclerosis. In search of its etio-pathogenic mechanisms].
    Bonduelle M
    Recenti Prog Med; 1989 Dec; 80(12):659-64. PubMed ID: 2697901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel missense (C7W) mutation of SOD1 in a large familial amyotrophic lateral sclerosis pedigree.
    Wang Z; Cai W; Cui F; Cai T; Chen Z; Mao F; Teng H; Chen L; Wang J; Sun Z; Huang X; Yu P
    Neurobiol Aging; 2014 Mar; 35(3):725.e11-5. PubMed ID: 24094577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-Fas antibody levels in amyotrophic lateral sclerosis.
    Sengun IS; Appel SH
    J Neuroimmunol; 2003 Sep; 142(1-2):137-40. PubMed ID: 14512172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The etiopathogenesis of amyotrophic lateral sclerosis--recent development].
    Yase Y
    Nihon Rinsho; 1992 Apr; 50(4):900-6. PubMed ID: 1619777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial amyotrophic lateral sclerosis, 1850-1989: a statistical analysis of the world literature.
    Strong MJ; Hudson AJ; Alvord WG
    Can J Neurol Sci; 1991 Feb; 18(1):45-58. PubMed ID: 2036615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspects.
    Danysz W
    Expert Opin Investig Drugs; 2001 May; 10(5):985-9. PubMed ID: 11424902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
    Chen Y; Cao B; Chen X; Ou R; Wei Q; Zhao B; Wu Y; Yuan L; Shang HF
    Neurosci Lett; 2018 Nov; 686():205-210. PubMed ID: 30144538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogranin A levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Verde F; Steinacker P; Oeckl P; Weishaupt JH; Rosenbohm A; Silani V; Ludolph AC; Otto M
    Neurobiol Aging; 2018 Jul; 67():21-22. PubMed ID: 29609078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Alzheimer disease and amyotrophic lateral sclerosis?
    Sadovnick AD
    Can J Neurol Sci; 1990 Aug; 17(3):352. PubMed ID: 2207894
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and molecular analysis of neurodegenerative diseases.
    Abe K
    Tohoku J Exp Med; 1997 Apr; 181(4):389-409. PubMed ID: 9210248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traumatic brain injury: a risk factor for neurodegenerative diseases.
    Gupta R; Sen N
    Rev Neurosci; 2016 Jan; 27(1):93-100. PubMed ID: 26352199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer disease pathology in amyotrophic lateral sclerosis.
    Hamilton RL; Bowser R
    Acta Neuropathol; 2004 Jun; 107(6):515-22. PubMed ID: 15024584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of amyotrophic lateral sclerosis.
    Talbott EO; Malek AM; Lacomis D
    Handb Clin Neurol; 2016; 138():225-38. PubMed ID: 27637961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.